Hydroxychloroquine Market to witness massive gains amidst expanding COVID-19 cases | Cipla, Sanofi S.A., Intas Pharmaceuticals, Laurus Labs, Covis Pharmaceuticals

The number of COVID-19 cases is massively rising across the globe, while no specific treatment or medication has been proved to completely abate its spread so far. However, the drug hydroxychloroquine seems to have brought about a massive change in the treatment of this virus. Hydroxychloroquine is a medication used for the treatment and prevention of malaria in areas where the disease remains sensitive to chloroquine. Hydroxychloroquine Market growth is fostered by increasing hydroxychloroquine drug demand for treat the patients because rising coronavirus cases globally.

According to reliable sources, hydroxychloroquine has received an FDA nod as a possible treatment for the COVID-19. This potential drug is currently being tested on more than over 1,500 corona positive patients in the province of New York.

Get detailed COVID-19 impact analysis on the hydroxychloroquine market @ https://www.gminsights.com/request-sample/detail/4629

It is imperative to mention that India has emerged as a primary network for the distribution of hydroxychloroquine drug. For the record, the country has been exporting these drugs to nearly 55 worst hit countries, one of them being the United States. The country has recorded a drastic rise in the number of coronavirus cases from early March to this date. There are more than 6,50,000 corona positive patients in the country as of now. Rise in patient count had urged the States to import hydroxychloroquine drugs from India following which President of the country, Donald Trump, had asked Indian Prime Minister, Narendra Modi to lift the ban on the export of anti-malaria drug on humanitarian grounds.

Post the conversation between the two prominent leaders, India released the shipment of 35.82 lakh tablets of hydroxychloroquine to the United States, in line with over nine metric tons of active API or pharmaceutical requirements needed for the production of this drug. The PM of India, Mr. Modi, regarded this step as a support in the battle against this pandemic. This dynamic spurt in drug demand has driven the growth of the regional hydroxychloroquine market share.

Company profiled in hydroxychloroquine market report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:

1. Intas Pharmaceuticals
2. McW Healthcare of Indore
3. Macleods Pharmaceuticals
4. Cipla
5. Novartis International AG
6. Sanofi S.A.
7. Amneal Pharmaceuticals, Inc.
8. Laurus Labs Limited
9. Covis Pharmaceuticals, Inc

Make an inquiry for buying this report @ https://www.gminsights.com/inquiry-before-buying/4629

In line with this, researchers in the United States are extensively working towards determining the positive effects of hydroxychloroquine in curtailing the disease spread. It has been reported that researchers at NYU Langone introduced one of the nation's largest hydroxychloroquine analysis and enrolled their first patient 10 days prior to the launch. Additionally, federal health regulators have hastened their approvals for coronavirus research.

Although the drug is being exported to vivid countries under the label as 'miracle drug', various states across India have banned 'over the counter' sales of the same. Odisha Government, for instance, has directed chemists not to sell hydroxychloroquine over the counter after it was discovered that people across the state have stockpiled these due to raging coronavirus fear. This advisory was issued as per the recommendation of taskforce constituted by the ICMR. The Health and Family Welfare department has also urged people to not consume any medication without a doctor prescription.

Browse complete summary of this research report @ https://www.gminsights.com/industry-analysis/hydroxychloroquine-market

Confirming the statement, the family of a 65-year-old woman residing in New York blamed the drug for causing her a fatal cardiac arrest after she was prescribed the malaria drug for treating coronavirus symptoms. Similar such allegation are likely to impact the hydroxychloroquine market demand.

Browse More News -

Hydroxychloroquine Sulfate Market Trends: https://www.marketwatch.com/press-release/hydroxychloroquine-sulfate-market-is-growing-rapidly-due-to-its-tablets-are-widely-used-in-treating-malaria-in-the-coronavirus-cases-2020-04-20

Caustic Soda Market Size: https://www.globenewswire.com/news-release/2020/05/07/2029160/0/en/Caustic-Soda-Market-valuation-to-exceed-32-06-billion-by-2026-Says-Global-Market-Insights-Inc.html

Titanium Dioxide Market Size: https://www.globenewswire.com/news-release/2020/04/01/2010390/0/en/Titanium-Dioxide-Market-is-slated-to-surpass-27-billion-by-2026-Says-Global-Market-Insights-Inc.html

Contact Us
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

This release was published on openPR.